# A Clinical Study to Evaluate the Potential Role of ACTH Gel in Patients With Scleritis

> **NCT03465111** · PHASE2 · UNKNOWN · sponsor: **Metropolitan Eye Research & Surgery Institute** · enrollment: 30 (estimated)

## Conditions studied

- Scleritis

## Interventions

- **DRUG:** ACTH (adrenocorticotropic hormone) gel

## Key facts

- **NCT ID:** NCT03465111
- **Lead sponsor:** Metropolitan Eye Research & Surgery Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-01
- **Primary completion:** 2024-12-08
- **Final completion:** 2024-12-08
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2023-10-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03465111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03465111, "A Clinical Study to Evaluate the Potential Role of ACTH Gel in Patients With Scleritis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03465111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*